title: Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
authors.affiliation: Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York, New York, USA.
authors.forename: Tracey N
authors.initials: TN
authors.lastname: Liebman
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Stein
authors.forename: David
authors.initials: D
authors.lastname: Polsky
mesh_terms: D000818:Animals; D002280:Basal Cell Carcinoma / Q000517:prevention & control*; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D004008:Diclofenac / Q000627:therapeutic use; D006801:Humans; D055623:Keratosis, Actinic / Q000188:drug therapy / Q000517:prevention & control*; D011720:Pyrazoles / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000517:prevention & control*; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib